ROTEM-guided Transfusion Protocol Versus Standard Care in Attempt to Reduce Blood Transfusions in Potentially Curative Major Abdominal and Urological Oncological Surgery
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Blood Loss, Surgical
- Sponsor
- Tampere University Hospital
- Locations
- 1
- Primary Endpoint
- Number of transfused red blood cell (RBC) units
- Status
- Withdrawn
- Last Updated
- 5 years ago
Overview
Brief Summary
Need for perioperative blood transfusion is still high in certain types of oncological abdominal surgery. Allogeneic blood transfusion may be detrimental in cancer patients undergoing a potentially curative resection of malignant tumor, although the detailed mechanism of this effect is still under debate. We plan to evaluate whether a new, rotational thromboelastography-guided algorithm (ROTEM) to guide hemostatic resuscitation intra-operatively decreases the use of allogeneic blood products, the total amount of bleeding, transfusion related side effects, thromboembolic complications and costs. Its effect on each patient's post-operative hemostatic profile is also measured. 60 patients having a potentially curative pancreaticoduodenectomy (or resection of cauda of pancreas), total removal or partial resection of kidney and open radical cystectomy are recruited when an active blood loss of more than 1500 ml is estimated and/or measured and are randomized into two groups: one will be treated conventionally, ie. using massive transfusion protocol (MTP) if necessary, clinical judgement and conventional coagulation tests, the other treated using a ROTEM-based algorithm.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age over 18, radical cystectomy, total or partial nephrectomy for malignant disease or pancreaticoduodenectomy planned and estimated intraoperative hemorrhage over 1500ml, written and informed consent
Exclusion Criteria
- •Known hemophilia or von Willebrandt's disease (treatment planned beforehand in collaboration with haematologist), unacceptance of allogeneic blood products (jehovah's witnesses).
Outcomes
Primary Outcomes
Number of transfused red blood cell (RBC) units
Time Frame: 24 hours after beginning of surgery
Red blood cell units transfused per patient during operation or up to 24 hours after beginning of surgery
Secondary Outcomes
- Intensive care admissions(30 days after surgery)
- Length of hospital stay(30 days after surgery)
- Transfusion-related side effects(30 days after surgery)
- Thromboembolic events(30 days after surgery)